Awiqli Is Here: Fewer Insulin Shots Could Change Diabetes Care, But Can Patients Afford and Access It?
The first FDA-approved once-weekly basal insulin is entering the U.S. market. For ... more
The first FDA-approved once-weekly basal insulin is entering the U.S. market. For ... more
A new federal inflation report shows prescription-drug prices fell 3.1% over the ... more
The newly approved medication offers a needle-free option for adults with high ... more
A nationwide wave of prescription and over-the-counter eye drop recalls includes products ... more
A new Medicare pilot program opens access to popular weight-loss medications for ... more
As GLP-1 medications like Ozempic and Mounjaro become common in American homes, ... more
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Connect with us